{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:15:12Z","timestamp":1793643312556,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T00:00:00Z","timestamp":1176249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s10620-006-9250-x","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T06:58:06Z","timestamp":1176879486000},"page":"1481-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":183,"title":["Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases"],"prefix":"10.1007","volume":"52","author":[{"given":"Nirmal","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Mahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,11]]},"reference":[{"key":"9250_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2249.1990.tb03334.x","volume":"81","author":"TT MacDonald","year":"1990","unstructured":"MacDonald TT, Hutchings P, Choy MY, et\u00a0al. (1990) Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301","journal-title":"Clin Exp Immunol"},{"key":"9250_CR2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/gut.32.8.913","volume":"32","author":"SH Murch","year":"1991","unstructured":"Murch SH, Lamkin VA, Savage MO, et\u00a0al. (1991) Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 32:913\u2013917","journal-title":"Gut"},{"key":"9250_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","volume":"339","author":"CP Braegger","year":"1992","unstructured":"Braegger CP, Nicholls S, Murch SH, et\u00a0al. (1992) Tumour necrosis factor-alpha in stool as a marker of intestinal inflammation. Lancet 339:89\u201391","journal-title":"Lancet"},{"key":"9250_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529\u2013543","journal-title":"Front Biosci"},{"key":"9250_CR5","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","volume":"159","author":"AE Plevy","year":"1997","unstructured":"Plevy AE, Landers CJ, Prehn J, et\u00a0al. (1997) A role for TNF-a and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159:6276\u20136282","journal-title":"J Immunol"},{"key":"9250_CR6","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/art.1780390703","volume":"39","author":"EM Paleolog","year":"1996","unstructured":"Paleolog EM, Hunt M, Elliott MJ, et\u00a0al. (1996) Deactivation of vascular endothelium by monoclonal anti\u2013tumor necrosis factor alpha antibody in rheumatoid arthritis. Arth Rheum 39:1082\u20131091","journal-title":"Arth Rheum"},{"key":"9250_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jcb.240530404","volume":"53","author":"A Mauviel","year":"1993","unstructured":"Mauviel A (1993) Cytokine regulation of metalloproteinase gene expression. J Cell Biochem 53:288\u2013295","journal-title":"J Cell Biochem"},{"key":"9250_CR8","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.4049\/jimmunol.151.9.4637","volume":"151","author":"LA Tartaglia","year":"1993","unstructured":"Tartaglia LA, Goeddel DV, Reynolds C, et\u00a0al. (1993) Stimulation of human T cell proliferation by specific activation of the 75-kDa tumour necrosis factor receptor. J Immunol 151:4637\u20134641","journal-title":"J Immunol"},{"key":"9250_CR9","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, et\u00a0al. (1999) Infliximab for the treatment of fistulas in patients with Crohn's Disease. N Engl J Med 340:1398\u20131405","journal-title":"N Engl J Med"},{"key":"9250_CR10","unstructured":"Parks M: Personal communication, Centocor Inc."},{"key":"9250_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1345\/aph.1C249","volume":"37","author":"RN Serio","year":"2003","unstructured":"Serio RN (2003) Infliximab treatment of sarcoidosis. Ann Pharmacother 37:577\u2013581","journal-title":"Ann Pharmacother"},{"key":"9250_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00063030-200519010-00006","volume":"19","author":"AM Tobin","year":"2005","unstructured":"Tobin AM, Kirby B (2005) TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. Biodrugs 19:47\u201357","journal-title":"Biodrugs"},{"key":"9250_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1517\/14656566.5.7.1497","volume":"5","author":"D Wendling","year":"2004","unstructured":"Wendling D, Toussirot E (2004) Anti-TNF-alpha therapy in ankylosing spondylitis. Expert Opin Pharmacother 5:1497\u20131507","journal-title":"Expert Opin Pharmacother"},{"key":"9250_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/rheumatology\/keg294","volume":"42","author":"P Lamprecht","year":"2003","unstructured":"Lamprecht P, Voswinkel J, Lilienthal T, et\u00a0al. (2003) Effectiveness of TNF\u2013alpha blockade with infliximab in refractory Wegener's granulomatosis [Comment]. Rheumatology 42:1124\u20131125","journal-title":"Rheumatology"},{"key":"9250_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(89)90430-3","volume":"2","author":"FM Brennan","year":"1989","unstructured":"Brennan FM, Chantry D, Jackson A, et\u00a0al. (1989) Inhibitory effect of TNF\u2013a antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244\u2013247","journal-title":"Lancet"},{"key":"9250_CR16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, et\u00a0al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"9250_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","volume":"344","author":"A Warris","year":"2001","unstructured":"Warris A (2001) Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 344:1099\u20131100","journal-title":"N Engl J Med"},{"key":"9250_CR18","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/art.10583","volume":"46","author":"JH Lee","year":"2002","unstructured":"Lee JH, Slifman NR, Gershon SK, et\u00a0al. (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arth Rheum 46:2565\u20132670","journal-title":"Arth Rheum"},{"key":"9250_CR19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/00042737-200212000-00018","volume":"14","author":"D Helbling","year":"2002","unstructured":"Helbling D, Breichtback TH, Kraus M (2002) Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol 14:1393\u20131395","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9250_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","volume":"95","author":"J Morelli","year":"2000","unstructured":"Morelli J, Wilson FA (2000) Does infliximab therapy increase susceptibility to listeriosis? Am J Gastroenterol 95:841\u2013842","journal-title":"Am J Gastroenterol"},{"key":"9250_CR21","first-page":"606","volume":"49","author":"RK Shrestha","year":"2004","unstructured":"Shrestha RK, Stoller JK, Honari G, et\u00a0al. (2004) Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel. Respir Care 49:606\u2013608","journal-title":"Respir Care"},{"key":"9250_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/00365540410021171","volume":"37","author":"I Katsarolis","year":"2005","unstructured":"Katsarolis I, Tsiodras S, Panagopoulos P, et\u00a0al. (2005) Septic arthritis due to Salmonella enteritidis associated with infliximab use. Scand J Infect Dis 37:304\u2013305","journal-title":"Scand J Infect Dis"},{"key":"9250_CR23","first-page":"2517","volume":"31","author":"H Vonkeman","year":"2004","unstructured":"Vonkeman H, ten Napel C, Rasker H, et\u00a0al. (2004) Disseminated primary varicella infection during infliximab treatment. J Rheumatol 31:2517\u20132518","journal-title":"J Rheumatol"},{"key":"9250_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1503\/cmaj.1040563","volume":"171","author":"SM Singh","year":"2004","unstructured":"Singh SM, Rau NV, Cohen LB, et\u00a0al. (2004) Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone. Can Med Assoc J 171:1063\u20131064","journal-title":"Can Med Assoc J"},{"key":"9250_CR25","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR, et\u00a0al. (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arth Rheum 44:2862\u20132869","journal-title":"Arth Rheum"},{"key":"9250_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1023\/B:DDAS.0000042246.58984.98","volume":"49","author":"N Kaur","year":"2004","unstructured":"Kaur N, Mahl TC (2004) Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease. Dig Dis Sci 49:1458\u20131460","journal-title":"Dig Dis Sci"},{"key":"9250_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/rheumatology\/41.8.951","volume":"41","author":"TL Tai","year":"2002","unstructured":"Tai TL, O'Rourke P, McWeeney M, et\u00a0al. (2002) Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology 41:951\u2013952","journal-title":"Rheumatology"},{"key":"9250_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/01.MIB.0000164002.32735.c2","volume":"11","author":"M Seddik","year":"2005","unstructured":"Seddik M, Melliez H, Seguy D, et\u00a0al. (2005) Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease. Inflamm Bowel Dis 11:618\u2013620","journal-title":"Inflamm Bowel Dis"},{"key":"9250_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/00054725-200409000-00025","volume":"10","author":"FS Velayos","year":"2004","unstructured":"Velayos FS, Sandborn WJ (2004) Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease. Inflamm Bowel Dis 10:657\u2013660","journal-title":"Inflamm Bowel Dis"},{"key":"9250_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1378\/chest.118.3.704","volume":"118","author":"NG Mansharamani","year":"2000","unstructured":"Mansharamani NG, Garland R, Delaney D, Koziel H (2000) Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985\u20131995. Chest 118:704\u2013711","journal-title":"Chest"},{"key":"9250_CR31","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jama.281.9.824","volume":"281","author":"T Brewer","year":"1999","unstructured":"Brewer T, Colditz GA (1999) Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 281:824\u2013829","journal-title":"JAMA"},{"key":"9250_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10067-004-0900-0","volume":"23","author":"M Marinosa","year":"2004","unstructured":"Marinosa M, Soler A, Nogues X, et\u00a0al. (2004) Pulmonary coinfection by Pneumocystis carinii and Aspergillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate. Clin Rheumatol 23:555\u2013556","journal-title":"Clin Rheumatol"},{"key":"9250_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1398-9995.1997.tb00968.x","volume":"52","author":"AG Oehling","year":"1997","unstructured":"Oehling AG, Akdis CA, Schapowal A, et\u00a0al. (1997) Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 52:144\u2013154","journal-title":"Allergy"},{"key":"9250_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","volume":"116","author":"FJ Baert","year":"1999","unstructured":"Baert FJ, D'Haens GR, Peeters M, et\u00a0al. (1999) Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22\u201328","journal-title":"Gastroenterology"},{"key":"9250_CR35","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","volume":"124","author":"JMH Van Den Brande","year":"2003","unstructured":"Van Den Brande JMH, Braat H, Van Den Brink GR, et\u00a0al. (2003) Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 124:1774\u20131785","journal-title":"Gastroenterology"},{"key":"9250_CR36","first-page":"247","volume":"23","author":"EG Favalli","year":"2005","unstructured":"Favalli EG, Varenna M, Sinigaglia L (2005) Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clin Exp Rheumatol 23:247\u2013250","journal-title":"Clin Exp Rheumatol"},{"key":"9250_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands BE, Anderson FH, Bernstein CN, et\u00a0al. (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350:876\u2013885","journal-title":"N Engl J Med"},{"key":"9250_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","volume":"126","author":"JF Colombel","year":"2004","unstructured":"Colombel JF, Loftus EV, Tremaine WJ, et\u00a0al. (2004) The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients. Gastroenterology 126:19\u201331","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-006-9250-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9250-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-006-9250-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T08:11:13Z","timestamp":1707811873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-006-9250-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["9250"],"URL":"https:\/\/doi.org\/10.1007\/s10620-006-9250-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1105196.561391","asserted-by":"object"}]},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,11]]},"assertion":[{"value":"22 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}